Mark Jelley

Mark Jelley is a Partner at OrbiMed Advisors based in New York, where he specializes in structured finance and royalty investments across the healthcare sector. Since joining the firm in 2012, he has contributed to the Credit and Royalty team, managing investments that span from seed-stage venture capital to large publicly traded companies. Prior to his current position, Jelley served as an Associate in the Financial Sponsors and Leveraged Finance Group at UBS Investment Bank from 2010 to 2012. He began his financial career as an Analyst in Principal Investing at Macquarie Group between 2008 and 2010. Jelley holds a Bachelor of Science in Chemistry and Biology from Duke University, which he completed in 2008. His professional focus remains centered on providing specialized credit solutions to biopharmaceutical, medical device, and digital health enterprises.